v3.25.3
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Treasury Stock Receivable
Retained Earnings
Accumulated Other Comprehensive Loss
Total SBC Medical Group Holdings Incorporated's Stockholders' Equity
Non Controling Interest
Balance at Dec. 31, 2023 $ 143,810,249 $ 9,419 $ 36,879,281     $ 142,848,732 $ (37,578,255) $ 142,159,177 $ 1,651,072
Balance, shares at Dec. 31, 2023   94,192,433              
Net income 18,750,216         18,757,752   18,757,752 (7,536)
Foreign currency translation adjustment (10,193,852)           (10,109,388) (10,109,388) (84,464)
Disposal of subsidiary (1,221,795)               (1,221,795)
Balance at Mar. 31, 2024 151,144,818 $ 9,419 36,879,281     161,606,484 (47,687,643) 150,807,541 337,277
Balance, shares at Mar. 31, 2024   94,192,433              
Balance at Dec. 31, 2023 143,810,249 $ 9,419 36,879,281     142,848,732 (37,578,255) 142,159,177 1,651,072
Balance, shares at Dec. 31, 2023   94,192,433              
Net income 40,142,008                
Balance at Sep. 30, 2024 205,520,424 $ 10,302 60,825,115   $ (2,700,000) 182,923,786 (36,078,149) 204,981,054 539,370
Balance, shares at Sep. 30, 2024   103,020,816              
Balance at Mar. 31, 2024 151,144,818 $ 9,419 36,879,281     161,606,484 (47,687,643) 150,807,541 337,277
Balance, shares at Mar. 31, 2024   94,192,433              
Net income 18,557,325         18,484,408   18,484,408 72,917
Foreign currency translation adjustment (9,046,549)           (8,995,632) (8,995,632) (50,917)
Balance at Jun. 30, 2024 160,655,594 $ 9,419 36,879,281     180,090,892 (56,683,275) 160,296,317 359,277
Balance, shares at Jun. 30, 2024   94,192,433              
Issuance of common stock as incentive shares   $ 34 (34)            
Issuance of common stock as incentive shares, Shares   339,565              
Reverse recapitalization, net of transaction costs ,shares   5,080,820              
Reverse recapitalization, net of transaction costs 8,407,888 $ 508 8,407,380         8,407,888  
Issuance of common stock to settle convertible note   $ 27 2,699,973   (2,700,000)        
Issuance of common stock to settle convertible note, Shares   270,000              
Stock-based compensation 12,807,455   12,807,455         12,807,455  
Issuance of common stock from exercise of stock warrants 31,374 $ 314 31,060         31,374  
Issuance of common stock from exercise of stock warrants, Shares   3,137,998              
Net income 2,834,467         2,832,894   2,832,894 1,573
Foreign currency translation adjustment 20,783,646           20,605,126 20,605,126 178,520
Balance at Sep. 30, 2024 205,520,424 $ 10,302 60,825,115   $ (2,700,000) 182,923,786 (36,078,149) 204,981,054 539,370
Balance, shares at Sep. 30, 2024   103,020,816              
Balance at Dec. 31, 2024 $ 195,022,158 $ 10,302 62,513,923 $ (2,700,000)   189,463,007 (54,178,075) 195,109,157 (86,999)
Balance, shares at Dec. 31, 2024   103,020,816              
Balance, shares at Dec. 31, 2024 270,000     (270,000)          
Issuance of common stock as incentive shares   $ 86 (86)            
Issuance of common stock as incentive shares, Shares   860,435              
Net income $ 21,491,950         21,502,446   21,502,446 (10,496)
Foreign currency translation adjustment 9,808,327           9,834,663 9,834,663 (26,336)
Balance at Mar. 31, 2025 226,322,435 $ 10,388 62,513,837 $ (2,700,000)   210,965,453 (44,343,412) 226,446,266 (123,831)
Balance, shares at Mar. 31, 2025   103,881,251              
Balance, shares at Mar. 31, 2025       (270,000)          
Balance at Dec. 31, 2024 $ 195,022,158 $ 10,302 62,513,923 $ (2,700,000)   189,463,007 (54,178,075) 195,109,157 (86,999)
Balance, shares at Dec. 31, 2024   103,020,816              
Balance, shares at Dec. 31, 2024 270,000     (270,000)          
Net income $ 36,765,128                
Balance at Sep. 30, 2025 $ 248,059,201 $ 10,388 72,196,114 $ (7,749,997)   226,248,329 (42,716,542) 247,988,292 70,909
Balance, shares at Sep. 30, 2025   103,881,251              
Balance, shares at Sep. 30, 2025 1,304,308     (1,304,308)          
Balance at Mar. 31, 2025 $ 226,322,435 $ 10,388 62,513,837 $ (2,700,000)   210,965,453 (44,343,412) 226,446,266 (123,831)
Balance, shares at Mar. 31, 2025   103,881,251              
Balance, shares at Mar. 31, 2025       (270,000)          
Net income 2,439,852         2,458,240   2,458,240 (18,388)
Foreign currency translation adjustment 8,623,269           8,420,470 8,420,470 202,799
Repurchase of common stock (2,415,262)     $ (2,415,262)       (2,415,262)  
Repurchase of common stock, shares       (512,809)          
Deemed contribution in connection with price modification on disposal of property and equipment 9,682,277   9,682,277         9,682,277  
Balance at Jun. 30, 2025 244,652,571 $ 10,388 72,196,114 $ (5,115,262)   213,423,693 (35,922,942) 244,591,991 (60,580)
Balance, shares at Jun. 30, 2025   103,881,251              
Balance, shares at Jun. 30, 2025       (782,809)          
Net income 12,833,326         12,824,636   12,824,636 (8,690)
Foreign currency translation adjustment (6,791,961)           (6,793,600) (6,793,600) 1,639
Repurchase of common stock (2,634,735)     $ (2,634,735)       (2,634,735)  
Repurchase of common stock, shares       (521,499)          
Balance at Sep. 30, 2025 $ 248,059,201 $ 10,388 $ 72,196,114 $ (7,749,997)   $ 226,248,329 $ (42,716,542) $ 247,988,292 $ 70,909
Balance, shares at Sep. 30, 2025   103,881,251              
Balance, shares at Sep. 30, 2025 1,304,308     (1,304,308)